Biowaiver for lower strength [Study Per­for­mance]

posted by luvblooms  – India, 2021-08-18 12:34 (584 d 07:47 ago) – Posting: # 22527
Views: 1,260

Hi Vishal

❝ clarification-after in vitro testing, the 2.5mg strength does not show proportional similarity and acceptable in vitro dissolution testing.


A common problem with drugs that have dose-dependent solubility.
The best way to handle this scenario is to go with does equivalent dissolution approach (assuming your formulation is dose-proportional).

Example:

2.5 mg *8 vs 20 mg
5 mg*4 vs 20
10mg *2 vs 20

There are few SBoA's available where FDA has recommended this approach.
I am trying to find those and will update the post if I am able to get those.

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
22,551 posts in 4,724 threads, 1,606 registered users;
13 visitors (0 registered, 13 guests [including 8 identified bots]).
Forum time: 19:21 CET (Europe/Vienna)

If there is an exception to any rule,
and if it can be proved by observation,
that rule is wrong.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5